Now accepting Telehealth appointments. Schedule a virtual visit.

Details of PRP Study, Supplements for Fertility and More - April 2018 VOICE Digest

When we are writing these words, the first quarter of 2018 is not even fully over yet, and CHR’s investigators have already seen 10 peer reviewed papers published according to PubMed. CHR is very obviously again looking at another record year in its research activities. We are particularly excited about our collaboration with the Brivanlou Laboratory for Stem Cell Biology and Molecular Embryology at Rockefeller University, where some truly remarkable things are happening. One project will be for the first time revealed by members of the Brivanlou Laboratory at CHR’s GrandRounds on Tuesday, April 10, 2018 at Jade Sixty, 116 East 60th Street. Reported data will have a very significant impact on the controversy swirling around preimplantation genetic screening (PGS), now also called preimplantation genetic testing for aneuploidy (PGT-A).

Capacity is limited. We, therefore, recommend early reservations for everybody who is interested in attending. As always, cocktails start at 6pm, followed by the GrandRounds lecture between 7-8pm and, finally, a sit-down dinner, starting at 8pm. For reservations, please email ykizawa@thechr.com.

In this issue of the VOICE, we cover:

Read this issue in PDF.

Norbert Gleicher, MD

Norbert Gleicher, MD, FACOG, FACS

Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.

Follow on LinkedIn    

Watch his videos on YouTube    

 


We have helped women bring over
17,800 babies into the world.

DISCOVER YOUR TREATMENT OPTIONS

 

You Might Also Enjoy...

The March/April Voice

Every issue of the VOICE slowly drifts towards more professional subjects, peaking with the literature review, which, primarily addresses physicians and scientists.
IVF in Alabama - What To Do Next?

IVF in Alabama - What To Do Next?

CHR offers the safe transfer of existing frozen embryos into our facility, ensuring continuity of care for patients affected by the suspension of IVF services in Alabama.

Should I Get an AMH Test?

Testing your anti-Mullerian hormone (AMH) levels can provide a lot of information about your ovarian reserve. Find out if you’d be a good candidate for an AMH test here.